Platelet derived growth factor (PDGF) responsive epidermis formed from human keratinocytes transduced with the PDGFβ receptor gene

Journal of Investigative Dermatology

Volumn 120, Issue 5, 2003, Pages 742-749

  Rollman, Ola ^a   Jensen, Uffe B ^b   Östman, Arne ^c   Bolund, Lars ^b   Gústafsdóttir, Sigrún M ^d   Jensen, Thomas G ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b AARHUS UNIVERSITY   (Denmark)

^c UPPSALA UNIVERSITY   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

Genetic transduction; Green fluorescent protein; PDGF receptor tyrosine kinase; Proximity ligation; Wound healing

Indexed keywords

GREEN FLUORESCENT PROTEIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR B;

ARTICLE; AUTOPHOSPHORYLATION; CELL COMPARTMENTALIZATION; CELL MIGRATION; CELL VIABILITY; EPIDERMIS CELL; EXTRACELLULAR MATRIX; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; KERATINOCYTE; MESENCHYME CELL; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; RECEPTOR GENE; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TISSUE CULTURE;

EID: 0038297579     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12129.x     Document Type: Article

References (50)

1. Ansel JC, Tiesman JP, Olerud JE, et al: Human keratinocytes are a major source of cutaneous platelet derived growth factor. J Clin Invest 92:671-678, 1993
2. Antoniades HN, Galanopoulos T, Neville-Golden J, Kiritsy CP, Lynch SE: Injury induces in vivo expression of platelet-derived growth factor (PDGF) and PDGF receptor mRNAs in skin epithelial cells and PDGF mRNA in connective tissue fibroblasts. Proc Natl Acad Sci 88:565-569, 1991
3. Beer HD, Longaker MT, Werner S: Reduced expression of PDGF and PDGF receptors during impaired wound healing. J Invest Dermatol 109:132-138, 1997
4. Breitbart AS, Grande DA, Laser J, et al: Treatment of ischemic wounds using cultured dermal fibroblasts transduced retrovirally with PDGF-B and VEGF121 genes. Ann Plast Surg 46:555-561, 2001
5. Castelijns FA, Gerritsen MJ, van Vlijmen-Willems IM, van Erp PJ. van de Kerkhof PC: Proliferation is the main epidermal target in the treatment of psoriatic plaques with once daily application of tacalcitol ointment. Acta Derm Venereol 79:111-114, 1999
6. Chuah MK, Vandendriessehe T, Morgan RA: Development and analysis of retroviral vectors expressing human factor VIII as a potential gent therapy for haemophilia A. Hum Gene Ther 6:1363-1377, 1995
7. Claesson-Welsh L, Eriksson A, Moren A, et al: cDNA cloning and expression of a human platelet-derived growth factor (PDGF) receptor specific for B-chain-containing PDGF molecules. Mol Cell Biol 8:3476-3486, 1988
8. Cooper DM, Yu EZ, Hennessey P, Ko F, Robson MC: Determination of endogenous cytokines in chronic wounds. Ann Surg 219:688-691, 1994
9. Embil JM, Papp K, Sibbald G, Tousignant J, Smiell JM, Wong B, Lau CY: Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: An open-label clinical evaluation of efficacy. Wound Repair Regen 8:162-168, 2000
10. Eming SA, Lee J, Snow RG, Tompkins RG, Yarmush ML, Morgan JR: Genetically modified human epidermis over-expressing PDGF-A directs the development of a cellular and vascular connective tissue stroma when transplanted to athymic mice - implications for the use of genetically modified keratinocytes to modulate dermal regeneration. J Invest Dermatol 105:756-763, 1995
11. Eming SA, Medalie DA, Tompkins RG, Yarmush ML, Morgan JR: Genetically modified human keratinocytes overexpressing PDGF-A enhance the performance of a composite skin graft. Hum Gene Ther 1:529-539, 1998
12. Eming SA, Yarmush ML, Krueger GG, Morgan JR: Regulation of the spatial organization of mesenchymal connective tissue: effects of cell-associated versus released isoforms of platelet-derived growth factor. Am J Pathol 154:281-289, 1999
13. Fredriksson S, Gullberg M, Jarvius J, et al: Protein detection using proximity-dependent DNA ligation assays. Nat Biotechnol 20:473-477, 2002
14. Freeman AE, Igel HJ, Herrman BJ, Kleinfeld KL: Growth and characterization of human skin epithelial cell cultures. In Vitro 12:352-362, 1976
15. Garlick JA, Katz AB, Fenjves ES, Taichman LB: Retrovirus-mediated transduction of cultured epidermal keratinocytes. J Invest Dermatol 97:824-829, 1991
16. Gibbs S, Silva Pinto AN, Murli S, Huber M, Hohl D, Ponec M: Epidermal growth factor and keratinocyte growth factor differentially regulate epidermal migration, growth, and differentiation. Wound Repair Regen 8:192-203, 2000
17. Grayson LS, Hansbrough JF, Zapata-Sirvent RL, Dore CA, Morgan JL, Nicolson MA: Quantitation of cytokine levels in skin graft donor site wound fuid. Burns 19:401-405, 1993
18. Gubin AN, Koduru S, Njoroge JM, Bhatnagar R, Miller JL: Stable expression of green fluorescent protein after liposomal transfection of K562 cells without selective growth conditions. Biotechniques 27:1162-1170, 1999
19. Hanazono Y, Yu JM, Dunbar CE, Emmons RV: Green fluorescent protein retroviral vectors: Low titer and high recombination frequency suggest a selective disadvantage. Hum Gene Ther 8:1313-1319, 1997
20. Hart CE, Seifert RA, Ross R, Bowen-Pope DF: Synthesis, phosphorylation, and degradation of multiple forms of the platelet-derived growth factor receptor studied using a monoclonal antibody. J Biol Chem 262:10780-10785, 1987
21. Heldin CH, Backstrom G, Östman A, et al: Binding of different dimeric forms of PDGF to human fibroblasts: Evidence for two separate receptor types. EMBO J 7:1387-1393, 1988
22. Heldin CH, Westermark B: Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79:1283-1316, 1999
23. Heldin CH, Westermark B, Wasteson A: Specific receptors for platelet-derived growth factor on cells derived from connective tissue and gila. Proc Natl Acad Sci 78:3664-3668, 1981
24. Jensen TG, Andresen BS, Jensen HK, et al: Rapid characterization of disease-causing mutations in the low density lipoprotein receptor gent (LDL-R) by overexpression in COS cells. Z Gastroenterol Suppl 3:9-12, 1996
25. Jensen TG, Sullivan DM, Morgan RA, Taichman LB, Nussenblatt RB, Blaese RM, Csaky KG: Retrovirus-mediated gene transfer of ornithine-delta-aminotransferase into keratinocytes from gyrate atrophy patients. Hum Gene Ther 8:2125-2132, 1997
26. Liechty KW, Nesbit M, Herlyn M, Radu A, Adzick NS, Crombleholme TM: Adenoviral-mediated over-expression of platelet-derived growth factor-B corrects ischemic impaired wound healing. J Invest Dermatol 113:375-383, 1999
27. Liu HS, January MS, Chou CK, Chen PH, Ke NJ: Is green fluorescent protein toxic to the living cells? Biochem Biophys Res Commun 260:712-717, 1999
28. Margolis DJ, Crombleholme T, Herlyn M: Clinical protocol. Phase 1 trial to evaluate the safety of H5.020CMV. PDGF-B for the treatment of a diabetic insensate foot ulcer. Wound Repair Regen 8:480-493, 2000
29. Markowitz D, Hesdorffer C, Ward M, Goff S, Bank A: Retroviral gene transfer using safe and efficient packaging cell lines. Ann N Y Acad Sci 612:407-414, 1990
30. Migliaccio AR, Bengra C, Ling J, et al: Stable and unstable transgene integration sites in the human genome: Extinction of the green fluorescent protein transgene in K562 cells. Gene 256:197-214, 2000
31. Moulin V, Lawny F, Barritault D, Caruelle JP: Platelet releasate treatment improves skin healing in diabetic rats through endogenous growth factor secretion. Cell Mol Biol 44:961-971, 1998
32. Nanney LB, Paulsen S, Davidson MK, Cardwell NL, Whitsitt JS, Davidson JM: Boosting epidermal growth factor receptor expression by gene gun transfection stimulates epidermal growth in vivo. Wound Repair Regen 8:117-127, 2000
33. Onodera M, Yachie A, Nelson DM, Welchlin H, Morgan RA, Blaese RM: A simple and reliable method for screening retroviral producer clones without selectable markers. Hum Gene Ther 8:1189-1194, 1997
34. Östman A, Bäkström G, Fong N, et al: Expression of three recombinant homodimeric isoforms of PDGF in Saccharomyces cerevisiae: evidence for difference in receptor binding and functional activities. Growth Factors 1:271-281, 1989
35. Ponec M, Gibbs S, Weerheim A, Kempenaar J, Mulder A, Mommaas AM: Epidermal growth factor and temperature regulate keratinocyte differentiation. Arch Dermatol Res 289:317-326, 1997
36. Rees RS, Robson MC, Smiell JM, Perry BH: Becaplermin gel in the treatment of pressure ulcers: A phase II randomized, double-blind, placebo-controlled study. Wound Repair Regen 7:141-147, 1999
37. Regnier M, Asselineau D, Lenoir MC: Human epidermis reconstructed on dermal substrates in vitro: An alternative to animals in skin pharmacology. Skin Pharmacol 3:70-85, 1990
38. Reuterdahl C, Sundberg C, Rubin K, Funa K, Gerdin B: Tissue localization of β receptors for platelet-derived growth factor and platelet-derived growth factor B chain during wound repair in humans. J Clin Invest 91:2065-2075, 1993
39. Rheinwald JG, Green H: Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6:331-343, 1975
40. Rikimaru K, Moles JP, Watt FM: Correlation between hyperproliferation and suprabasal integrin expression in human epidermis reconstituted in culture. Exp Dermatol 6:214-221, 1997
41. Robson MC, Phillips LG, Thomason A, Robson LE, Pierce GF: Platelet-derived growth factor BB for the treatment of chronic pressure ulcers. Lancet 339:23-25, 1992
42. Rubin K, Terracio L, Rönnstrand L, Heldin CH, Klareskog L: Expression of platelet-derived growth factor receptors is induced on connective tissue cells during chronic synovial inflammation. Scand J Immunol 27:285-294, 1988
43. Sambrook J, Fritsch EF, Maniatis T In: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1989
44. Shukla A, Dubey MP, Srivastava R, Srivastava BS: Differential expression of proteins during healing of cutaneous wounds in experimental normal and chronic models. Biochem Biophys Res Commun 244:434-439, 1998
45. Steed DL: Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group. J Vasc Surg 21:71-78, 1995
46. Stoler A, Kopan R, Duvic M, Fuchs E: Use of monospecific antisera and cRNA probes to localize the major changes in keratin expression during normal and abnormal epidermal differentiation. J Cell Biol 107:427-446, 1988
47. Supp DM, Bell SM, Morgan JR, Boyce ST: Genetic modification of cultured skin substitutes by transduction of human keratinocytes and fibroblasts with platelet-derived growth factor-A. Wound Repair Regen 8:26-35, 2000
48. Teumer J, Zezulak K, Green H: Measurement of specific mRNA content of keratinocytes of different sizes in relation to growth and differentiation. In: Leigh IM, Lane EB, Watt FM eds. The Keratinocyte Handbook, Cambridge: Cambridge University Press, 1994
49. Tyrone JW, Mogford JE, Chandler LA, Ma C, Xia Y, Pierce GF, Mustoe TA: Collagen-embedded platelet-derived growth factor DNA plasmid promotes wound healing in a dermal ulcer model. J Surg Res 93:230-236, 2000
50. Wieman TJ, Smiell JM, Su Y: Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study Diabetes Care 21:822-827, 1998